These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 32728686)
1. Structural and mechanistic analysis of ATPase inhibitors targeting mycobacterial DNA gyrase. Henderson SR; Stevenson CEM; Malone B; Zholnerovych Y; Mitchenall LA; Pichowicz M; McGarry DH; Cooper IR; Charrier C; Salisbury AM; Lawson DM; Maxwell A J Antimicrob Chemother; 2020 Oct; 75(10):2835-2842. PubMed ID: 32728686 [TBL] [Abstract][Full Text] [Related]
2. Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance. Gross CH; Parsons JD; Grossman TH; Charifson PS; Bellon S; Jernee J; Dwyer M; Chambers SP; Markland W; Botfield M; Raybuck SA Antimicrob Agents Chemother; 2003 Mar; 47(3):1037-46. PubMed ID: 12604539 [TBL] [Abstract][Full Text] [Related]
3. Streptococcus pneumononiae gyrase ATPase: development and validation of an assay for inhibitor discovery and characterization. Miller JR; Herberg JT; Tomilo M; McCroskey MC; Feilmeier BJ Anal Biochem; 2007 Jun; 365(1):132-43. PubMed ID: 17395144 [TBL] [Abstract][Full Text] [Related]
4. Ligand-Based Virtual Screening for Discovery of Indole Derivatives as Potent DNA Gyrase ATPase Inhibitors Active against Pakamwong B; Thongdee P; Kamsri B; Phusi N; Taveepanich S; Chayajarus K; Kamsri P; Punkvang A; Hannongbua S; Sangswan J; Suttisintong K; Sureram S; Kittakoop P; Hongmanee P; Santanirand P; Leanpolchareanchai J; Spencer J; Mulholland AJ; Pungpo P J Chem Inf Model; 2024 Aug; 64(15):5991-6002. PubMed ID: 38993154 [No Abstract] [Full Text] [Related]
6. Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase. Bellon S; Parsons JD; Wei Y; Hayakawa K; Swenson LL; Charifson PS; Lippke JA; Aldape R; Gross CH Antimicrob Agents Chemother; 2004 May; 48(5):1856-64. PubMed ID: 15105144 [TBL] [Abstract][Full Text] [Related]
7. Novel anti-tubercular and antibacterial based benzosuberone-thiazole moieties: Synthesis, molecular docking analysis, DNA gyrase supercoiling and ATPase activity. Omar MA; Masaret GS; Abbas EMH; Abdel-Aziz MM; Harras MF; Farghaly TA Bioorg Chem; 2020 Nov; 104():104316. PubMed ID: 33022549 [TBL] [Abstract][Full Text] [Related]
8. Structure-based drug repurposing to inhibit the DNA gyrase of Mycobacterium tuberculosis. Gl B; Rajput R; Gupta M; Dahiya P; Thakur JK; Bhatnagar R; Grover A Biochem J; 2020 Nov; 477(21):4167-4190. PubMed ID: 33030198 [TBL] [Abstract][Full Text] [Related]
9. Targeting novel sites in DNA gyrase for development of anti-microbials. Salman M; Sharma P; Kumar M; Ethayathulla AS; Kaur P Brief Funct Genomics; 2023 Apr; 22(2):180-194. PubMed ID: 36064602 [TBL] [Abstract][Full Text] [Related]
10. Simocyclinone D8, an inhibitor of DNA gyrase with a novel mode of action. Flatman RH; Howells AJ; Heide L; Fiedler HP; Maxwell A Antimicrob Agents Chemother; 2005 Mar; 49(3):1093-100. PubMed ID: 15728908 [TBL] [Abstract][Full Text] [Related]
12. The pentapeptide-repeat protein, MfpA, interacts with mycobacterial DNA gyrase as a DNA T-segment mimic. Feng L; Mundy JEA; Stevenson CEM; Mitchenall LA; Lawson DM; Mi K; Maxwell A Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836580 [TBL] [Abstract][Full Text] [Related]
13. Energy coupling in DNA gyrase and the mechanism of action of novobiocin. Sugino A; Higgins NP; Brown PO; Peebles CL; Cozzarelli NR Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4838-42. PubMed ID: 368801 [TBL] [Abstract][Full Text] [Related]
14. Characterization of quercetin binding site on DNA gyrase. Plaper A; Golob M; Hafner I; Oblak M; Solmajer T; Jerala R Biochem Biophys Res Commun; 2003 Jun; 306(2):530-6. PubMed ID: 12804597 [TBL] [Abstract][Full Text] [Related]
15. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study. Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559 [TBL] [Abstract][Full Text] [Related]
16. The interaction between coumarin drugs and DNA gyrase. Maxwell A Mol Microbiol; 1993 Aug; 9(4):681-6. PubMed ID: 8231802 [TBL] [Abstract][Full Text] [Related]
17. Biological activities of novel gyrase inhibitors of the aminocoumarin class. Anderle C; Stieger M; Burrell M; Reinelt S; Maxwell A; Page M; Heide L Antimicrob Agents Chemother; 2008 Jun; 52(6):1982-90. PubMed ID: 18347114 [TBL] [Abstract][Full Text] [Related]
18. Negative supercoiling of DNA by gyrase is inhibited in Salmonella enterica serovar Typhimurium during adaptation to acid stress. Colgan AM; Quinn HJ; Kary SC; Mitchenall LA; Maxwell A; Cameron ADS; Dorman CJ Mol Microbiol; 2018 Mar; 107(6):734-746. PubMed ID: 29352745 [TBL] [Abstract][Full Text] [Related]
19. The Antibiotic Novobiocin Binds and Activates the ATPase That Powers Lipopolysaccharide Transport. May JM; Owens TW; Mandler MD; Simpson BW; Lazarus MB; Sherman DJ; Davis RM; Okuda S; Massefski W; Ruiz N; Kahne D J Am Chem Soc; 2017 Dec; 139(48):17221-17224. PubMed ID: 29135241 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor. Nakada N; Gmünder H; Hirata T; Arisawa M Antimicrob Agents Chemother; 1994 Sep; 38(9):1966-73. PubMed ID: 7811004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]